Back to Bahl & Gaynor LLC Bahl & Gaynor LLC

ABTABT
30 quarters

Position history for Bahl & Gaynor LLCBahl & Gaynor LLC's holdings in Abbott Laboratories

Yes. Bahl & Gaynor holds 639,957 shares of ABT (Abbott Laboratories), worth $58.1M, as of its Q2 2026 13F filing. It reduced the position by 126,937 shares (-16.6%) from Q1 2026. Bahl & Gaynor has held ABT in every 13F on record since Q1 2019, 30 quarterly filings. ABT is 0.3% of Bahl & Gaynor's reported 13F portfolio.

Current Value

$58.1M

Current Shares

639,957

Total Value Change

-$178M

Total Shares Change

-2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
639,957
-16.6%
$58.1M0.3%$89.55
0
2026-Q1
Decreased
766,894
-14.1%
$78.7M0.4%$100.69
0
2025-Q4
Decreased
892,930
-0.5%
$111.9M0.6%$122.25
0
2025-Q3
Decreased
897,482
-7.4%
$120.2M0.6%$130.11
0
2025-Q2
Increased
969,054
+0.2%
$131.8M0.7%$131.53
42
2025-Q1
Decreased
966,888
-2.4%
$128.3M0.7%$127.69
0
2024-Q4
Decreased
990,460
-3.5%
$112M0.6%$108.31
0
2024-Q3
Decreased
1M
-26.9%
$117M0.6%$108.66
0
2024-Q2
Decreased
1.4M
-22.2%
$145.9M0.8%$98.52
0
2024-Q1
Decreased
1.8M
-0.3%
$205M1.1%$107.23
0
2023-Q4
Decreased
1.8M
-12.6%
$199.1M1.2%$103.34
0
2023-Q3
Decreased
2.1M
-17.3%
$200.4M1.3%$90.43
0
2023-Q2
Decreased
2.5M
-9.0%
$272.8M1.7%$101.31
0
2023-Q1
Increased
2.8M
+8.4%
$278.5M1.5%$93.63
53
2022-Q4
Decreased
2.5M
-8.2%
$278.7M1.7%$101.06
0
2022-Q3
Increased
2.8M
+6.2%
$267.6M1.8%$88.64
52
2022-Q2
Increased
2.6M
+30.0%
$282.9M1.9%$99.10
61
2022-Q1
Decreased
2M
-23.0%
$237.1M1.7%$107.52
0
2021-Q4
Decreased
2.6M
-2.9%
$366.2M2.0%$127.41
0
2021-Q3
Decreased
2.7M
-0.3%
$316.5M1.9%$106.53
0
2021-Q2
Increased
2.7M
+0.1%
$311.4M1.9%$104.15
49
2021-Q1
Decreased
2.7M
-2.2%
$321.5M2.0%$107.27
0
2020-Q4
Decreased
2.7M
-2.6%
$300.2M1.9%$97.61
0
2020-Q3
Decreased
2.8M
-1.1%
$306.5M2.2%$96.70
0
2020-Q2
Decreased
2.8M
-0.2%
$260.4M2.0%$80.92
0
2020-Q1
Decreased
2.9M
-7.7%
$225.3M2.0%$69.55
0
2019-Q4
Increased
3.1M
+0.4%
$268.6M1.9%$76.23
49
2019-Q3
Increased
3.1M
+1.7%
$257.8M1.9%$73.14
49
2019-Q2
Increased
3M
+2.5%
$254.7M1.9%$73.24
50
2019-Q1
First report
3M
-
$236.1M2.2%$69.33
0

Other major holders of ABT: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used